Concepedia

Mark R. Albertella

MR

20

Publications

2.7K

Citations

17

H-Index

1994

Active since

Affiliations

University of Cambridge(Current)

GW Pharmaceuticals (United Kingdom)

The Gurdon Institute

University of Oxford

University of Manchester

Mark R. Albertella is an author at University of Cambridge specializing in medicine, cell biology, and pharmacology.

Top concepts

MedicineCell BiologyPharmacologyTumor BiologyDrug DiscoveryCancer GeneticsCancer ResearchNatural SciencesMedicinal ChemistryChromatin

Publications per year

1994–2024

20

Publications

20

Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia

Eliza Yankova, Wesley Blackaby, Mark R. Albertella et al. · Nature · 2021 · 1.2K citations · Full text

Hematological Malignancy, Tumor Biology, Medicine +9

The overexpression of specialized DNA polymerases in cancer

Mark R. Albertella, Alan Lau, Mark J. O’Connor · DNA repair · 2005 · 247 citations

Chromatin, Natural Sciences, Dna Analysis +6

A Role for Polymerase η in the Cellular Tolerance to Cisplatin-Induced Damage

Mark R. Albertella, Catherine Green, Alan R. Lehmann et al. · Cancer Research · 2005 · 204 citations

Chromatin, Transcriptional Regulation, Genome Instability +14

Aneuploid colon cancer cells have a robust spindle checkpoint

Anthony Tighe, Victoria Johnson, Mark R. Albertella et al. · EMBO Reports · 2001 · 172 citations · Full text

Tumor Biology, Robust Spindle Checkpoint, Cell Division +7

Targeting the m<sup>6</sup>A RNA modification pathway blocks SARS-CoV-2 and HCoV-OC43 replication

Hannah M. Burgess, Daniel P. Depledge, Letitia Thompson et al. · Genes & Development · 2021 · 137 citations · Full text

Rows per page

1–5 of 20